No Evidence for Selection of HIV-1 with Enhanced Gag-Protease or Nef Function among Breakthrough Infections in the CAPRISA 004 Tenofovir Microbicide Trial

• Denis R. Chopera ,

  Contributed equally to this work with: Denis R. Chopera, Jaclyn K. Mann

  Affiliations HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa, KwaZulu-Natal Research Institute for Tuberculosis and HIV, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa, Institute of Infectious Disease and Molecular Medicine, and the Division of Medical Virology, University of Cape Town and National Health Laboratory Services, Cape Town, South Africa, Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada

  ⨯
• Jaclyn K. Mann ,

  Contributed equally to this work with: Denis R. Chopera, Jaclyn K. Mann

  Affiliation HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa

  ⨯
• Philip Mwimanzi,

  Affiliation Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada

  ⨯
• Saleha Omarjee,

  Affiliation HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa

  ⨯
• Xiaomei T. Kuang,

  Affiliation Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada

  ⨯
• Nonkululeko Ndabambi,

  Affiliation Institute of Infectious Disease and Molecular Medicine, and the Division of Medical Virology, University of Cape Town and National Health Laboratory Services, Cape Town, South Africa

  ⨯
• Sarah Goodier,

  Affiliation Institute of Infectious Disease and Molecular Medicine, and the Division of Medical Virology, University of Cape Town and National Health Laboratory Services, Cape Town, South Africa

  ⨯
• Eric Martin,

  Affiliations Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada

  ⨯
• Vivek Naranbhai,

  Affiliation Centre for the AIDS Programme of Research in South Africa, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa

  ⨯
• Salim Abdool Karim,

  Affiliation Centre for the AIDS Programme of Research in South Africa, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa

  ⨯
• Quarraisha Abdool Karim,

  Affiliation Centre for the AIDS Programme of Research in South Africa, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa

  ⨯
• Zabrina L. Brumme,

  Affiliations Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada

  ⨯
• Thumbi Ndung'u,

  Affiliations HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa, KwaZulu-Natal Research Institute for Tuberculosis and HIV, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa, Max Planck Institute for Infection Biology, Berlin, Germany

  ⨯
• Carolyn Williamson ,

  * E-mail: mark_brockman@sfu.ca (MAB); carolyn.williamson@uct.ac.za (CW)

  Affiliation Institute of Infectious Disease and Molecular Medicine, and the Division of Medical Virology, University of Cape Town and National Health Laboratory Services, Cape Town, South Africa

  ⨯
• Mark A. Brockman ,

  * E-mail: mark_brockman@sfu.ca (MAB); carolyn.williamson@uct.ac.za (CW)

  Affiliations Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada

  ⨯
•  [ ... ],
• the CAPRISA 004 TRAPS Team
• [ view all ]
• [ view less ]